Concepedia

Alison Tree

AT

Statistics

Publications

82

Citations

4.9K

H-Index

36

Active since

2009

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Clatterbridge Cancer Centre NHS Foundation Trust

Sunnybrook Health Science Centre

Alison Tree is an author at Institute of Cancer Research specializing in medicine, radiation therapy, and radiation oncology.

ORCID

Publications per year

2009–2025

82

Publications

82

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

, , +17

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

, , +16

Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis

Piet Ost, Barbara Alicja Jereczek‐Fossa, Nicholas van As et al. · European Urology · 2015 · 290 citations

, , +14

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

Gerard G. Hanna, Louise Murray, R. Patel et al. · Clinical Oncology · 2017 · 274 citations · Full text

, , +16

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer

Nicholas van As, Clare Griffin, Alison Tree et al. · New England Journal of Medicine · 2024 · 218 citations · Full text

, , +16

1–5 of 82